Detalhe da pesquisa
1.
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial.
Crit Care
; 27(1): 9, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36627655
2.
Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.
Cochrane Database Syst Rev
; (9): CD011230, 2014 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25220133
3.
EVITA: a tool for the early evaluation of pharmaceutical innovations with regard to therapeutic advantage.
BMC Clin Pharmacol
; 10: 5, 2010 Mar 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20233429
4.
Hospitalization rates of generic metoprolol compared with the original beta-blocker in an epidemiological database study.
Pharmacoepidemiol Drug Saf
; 16(12): 1298-307, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17957709
5.
Comparison of several point-of-care testing (POCT) glucometers with an established laboratory procedure for the diagnosis of type 2 diabetes using the discordance rate. A new statistical approach.
Clin Chem Lab Med
; 41(6): 809-20, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12880146
6.
Comparability of blood glucose concentrations measured in different sample systems for detecting glucose intolerance.
Clin Chem
; 48(6 Pt 1): 936-9, 2002 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12029012